510(k) Report

510(k) · Cleared

Cleared

NerveTape

K233533510(k) TraditionalCleared Feb 12, 2024102-day reviewClass II21 CFR 882.5275

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Biocircuit Technologies, Inc. · JXI Cuff, Nerve

Cleared on Feb 12, 2024 as substantially equivalent to K210665 (Biocircuit Technologies, Incorporated, 2022) after a 102-day review. Its family tree reaches back 6 generations to 1992.

Decided
Feb 12, 2024
Review
102 days
Class
Class II
Product code
JXI
Recalls
None
Predicates
1

Its longest line of descent runs back 6 generations to K921895 (1992). 14 ancestors in all, the oldest K830889 (1983). No later device cites it as a predicate yet.

  1. Root · 6 generations backK921895 Tissue Patch, Tissue GraftBio-Vascular, Inc. · 1992
  2. 5 generations backK961810 Supple Peri-Guard PericardiumBio-Vascular, Inc. · 1996
  3. 4 generations backK980431 SurgisisCook Biotech, Inc. · 1998
  4. 3 generations backK031069 Surgisis Nerve CuffCook Biotech, Inc. · 2003
  5. 2 generations backK132660 Nerve CuffCook Biotech Incorporated · 2014
  6. 1 generation backK210665 Nerve TapeBiocircuit Technologies, Incorporated · 2022
  7. This deviceK233533 NerveTapeBiocircuit Technologies, Inc. · 2024
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K921895Tissue Patch, Tissue GraftBio-Vascular, Inc.1992—
−5K961810Supple Peri-Guard PericardiumBio-Vascular, Inc.1996—
−4K980431SurgisisCook Biotech, Inc.1998—
−3K031069Surgisis Nerve CuffCook Biotech, Inc.2003—
−2K132660Nerve CuffCook Biotech Incorporated2014—
−1K210665Nerve TapeBiocircuit Technologies, Incorporated2022—
0 (this device)K233533NerveTapeBiocircuit Technologies, Inc.2024—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198310
198510
199210
199710
200010
200120
201610
FIG. 1 — Lineage of K233533, 1992–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JXI? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JXI device

  1. #1 K232029 VersaWrap Nerve Protectorscore 12.6 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K210665Nerve Tape
Summary page 5
…21 CFR §882.5275 (JXI) Class II E. Predicate Device: PRIMARY: BioCircuit Technologies, Inc. Nerve Tape™ (K210665) REFERENCE: AxoGuard® Nerve Connector (K162741) F. Physical Description: The proposed BioCircuit Techn…
Biocircuit Technologies, Incorporated2022—
†K162741AxoGuard Nerve ConnectorCook Biotech Incorporated2016—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 32 years and passes through 5 companies; a new generation was cleared every 5.0 years on median.
  • 1 of the 14 ancestors has a recall of any class.

How does its category compare?

All JXI devices

JXI Cuff, Nerve: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.

FDA decisions per year · JXI

4in 2025

2010: 12011: 12012: 12014: 32015: 12016: 32017: 32018: 12019: 12020: 12022: 22023: 32024: 32025: 42026 (partial year): 2
2007high 4 (2025) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JXI

99in 2025

2014: 309 days median2016: 117 days median2017: 90 days median2023: 122 days median2024: 266 days median2025: 99 days median
2007high 309 (2014) · low 90 (2017)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JXI

No recall names JXI since 2007.

Adverse event reports per year · JXI

18in 2025

2008: 72009: 72010: 82011: 112013: 72014: 72015: 52016: 82017: 92018: 62019: 102020: 52021: 32022: 82023: 152024: 182025: 18
2007high 18 (2024) · low 0 (2007)2025

MAUDE reports naming product code JXI, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—07
20090—07
20101—08
20111—011
20121—00
20130—07
2014330907
20151—05
2016311708
201739009
20181—06
20191—010
20201—05
20210—03
20222—08
20233122015
20243266018
2025499018
20262—0—

What is it indicated for?

NerveTape is indicated for the repair of peripheral nerve discontinuities where gap closure can be achieved by flexion of the extremity.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K233533: NerveTape.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K233533

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026